Emtricitabine/tenofovir (FTC/TDF (Truvada®))

DRUG2 trials

Sponsors

University of North Carolina, Chapel Hill

Conditions

HIV Infection

Phase 2

An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)

CompletedNCT01769456

University of North Carolina, Chapel HillHIV Infection

Start: 2013-03-31End: 2016-11-30Updated: 2018-01-17

An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis

CompletedNCT01772823

University of North Carolina, Chapel HillHIV Infection

Start: 2012-11-30End: 2015-11-30Updated: 2018-01-17

Related Papers

Changes in Bone Mass After Discontinuation of Preexposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113

Clinical Infectious Diseases2019-06-0719 citations

Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States

JAMA Pediatrics2017-09-05222 citations

Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing

Antimicrobial Agents and Chemotherapy2016-08-3073 citations